Strategy of leukocyte filtration for immunomodulation: Development of stainless steel leukocyte filter

Therapeutic Apheresis

Volumn 1, Issue 1, 1997, Pages 63-66

  Yamaji, Ken ^a   Yamane, Shingo ^a   Niimi, Yoshinari ^a   Sueoka, Akinori ^a   Nosé, Yukihiko ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokine; Immunomodulation; Interleukin 1 receptor antagonist; Leukocyte filter; Stainless steel

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; POLYESTER; STAINLESS STEEL;

ANTIBODY PRODUCTION; ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG ANTAGONISM; EQUIPMENT DESIGN; EVALUATION; HUMAN; IN VITRO STUDY; INSTRUMENTATION; LEUKAPHERESIS; LEUKOCYTE COUNT; METHODOLOGY; THROMBOCYTOPHERESIS;

ANTIBODY FORMATION; CYTOKINES; EQUIPMENT DESIGN; EVALUATION STUDIES; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; PLATELETPHERESIS; POLYESTERS; RECEPTORS, INTERLEUKIN-1; STAINLESS STEEL;

EID: 0031061132     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1997.tb00016.x     Document Type: Article

References (9)

1. Pflieger H. Graft-versus-host-disease following blood transfusions. Blut 1983;46:61-6.
2. Fisher M, Chapman JR, Tring A, Morris PJ. Alloimmunization to HLA antigens following transfusion with leucocyte-poor and purified platelet suspension. Vox Sang 1985;49: 331-5.
3. Sniecinski I, O'Donell MR, Nowicki B, Hill LR. Prevention of refractoriness and HLA alloimmunization using filtered blood products. Blood 1988;71:1402-7.
4. Andreu G, Dewailly J, Leberre C, Quarre MC, Bidet ML, Tardivel R, Devers L, Lam Y, Soreau E, Boccaccio C, Piard N, Bidet JM, Genetet B, Fauchet R. Prevention of HLA alloimmunization with leucocyte-poor packed red cells and platelet concentrates obtained by filtration. Blood 1988;72: 964-7.
5. Kickler TS, Bell W, Pall D. Depletion of white cells from platelet concentrates with a new adsorption filter. Transfusion 1989;29:411-4.
6. Haeffne-Cavaillon N, Kazatchkine MD. Methods for assessing monocytic cytokine production as an index of biocompatibility. Nephrol Dial Transplant 1994;9:112-5.
7. Seckinger P, Dayer JM. Interleukin-1 inhibitors. Ann Inst Pasteur Immunol 1987;138:461-516.
8. Balavoine JF, Rochemonteix B, Williamson K, Seckinger P, Cruchard A, Dayer JM. Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). J Clin Invest 1986;78:1120-4.
9. Granowitz EV, Mancilla J, Clark BD, Dinarello CA. The IL-1 receptor antagonist inhibits IL-1 binding to the type II IL-1 receptor. J Biol Cliem 1991;266:14147-50.